BioSpace News Archive

Business

Aptose Reports Results for the Fourth Quarter and Full Year 2022

Aptose Biosciences Inc. announced financial results for the fourth quarter and year ended December 31, 2022, and provided a corporate update.

March 23, 2023
·
18 min read
Pharm Country

Helius Medical Technologies, Inc. Announces Distribution of Series B Preferred Stock to Holders of its Class A Common Stock Intended to Facilitate a Reverse Stock Split, if Necessary

Helius Medical Technologies, Inc. announced that its Board of Directors declared a dividend of one one-thousandth of a share of newly designated Series B Preferred Stock, par value $0.001 per share, for each outstanding share of Helius Class A common stock held of record on April 3, 2023.

March 23, 2023
·
6 min read
Medtronic Announces Pricing of $2.0 Billion of Senior Notes

Medtronic plc announced that its wholly-owned subsidiary, Medtronic Global Holdings S.C.A., has priced an offering of $1,000,000,000 principal amount of 4.25% senior notes due 2028 and $1,000,000,000 principal amount of 4.50% senior notes due 2033.

March 23, 2023
·
3 min read
Biotech Bay

Agilent Presents 2023 Darlene Solomon Award to Victor Chang Cardiac Research Institute Scientist, Kathryn Wolhuter

Agilent Technologies Inc. announced that the recipient of the 2023 Darlene Solomon Award is Kathryn Wolhuter, Ph.D., a senior postdoctoral researcher studying coronary heart disease at the Victor Chang Cardiac Research Institute in Sydney, Australia.

March 23, 2023
·
3 min read
Business

Monte Rosa Therapeutics Appoints Dr. Jan Skvarka to Board of Directors

Monte Rosa Therapeutics, Inc. today announced the appointment of Jan Skvarka, Ph.D., MBA to its Board of Directors.

March 23, 2023
·
4 min read
Business

Enveric Biosciences Selects Australian CRO, Avance Clinical, in Preparation for Phase 1 Study of EB-373

Enveric Biosciences, Inc. today announced that it has entered into an agreement with Avance Clinical for its planned Phase 1 clinical trial of EB-373, the company’s lead candidate targeting the treatment of anxiety disorders.

March 23, 2023
·
6 min read
BioForest

Nautilus Biotechnology to Participate in B. Riley Securities’ Disruptive Biotech Enabling Technologies – Proteomics, Virtual Conference

Nautilus Biotechnology, Inc. today announced the company will be participating in the upcoming B. Riley Securities’ Disruptive Biotech Enabling Technologies – Proteomics, Virtual Conference.

March 23, 2023
·
1 min read
BioMidwest

Cardiometabolic Health Congress to Present at the National Lipid Association 2023 Scientific Sessions

As a leader in the field of research-based cardiorenal metabolic health education, CMHC is proud to partner with like-minded organizations such as the National Lipid Association, which offers its education-focused agenda to a wide number of lipid specialists representing all areas of the U.S.

March 23, 2023
·
2 min read
Drug Development

electroCore Reports Results of Pre-Clinical Trial in a Model of Traumatic Brain Injury

electroCore, Inc. today announced the publication of a paper entitled “Non-Invasive Vagus Nerve Stimulation Improves Brain Lesion Volume and Neurobehavioral Outcomes in a Rat Model of Traumatic Brain Injury” in the peer-reviewed Journal of Neurotrauma.

March 23, 2023
·
7 min read
Drug Development

Eledon to Present Data from Ongoing Phase 1b Trial Evaluating Tegoprubart in Kidney Transplantation at the World Congress of Nephrology 2023

Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced that the Company will present two posters at the upcoming International Society of Nephrology’s World Congress of Nephrology (WCN) 2023 meeting taking place in Bangkok, Thailand from March 30 – April 2, 2023.

March 23, 2023
·
1 min read